Effectivity of Cavinton and Lucidril in the treatment of hearing defects of different origin.
D006016:Glycolates / Q000627:therapeutic use*; D006311:Hearing Disorders / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D002504:Meclofenoxate / Q000627:therapeutic use*; D008875:Middle Aged; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014748:Vinca Alkaloids / Q000627:therapeutic use*
D006016:Glycolates; D014665:Vasodilator Agents; D014748:Vinca Alkaloids; C013983:vinpocetine; D002504:Meclofenoxate